John A. Bardi

John A. Bardi is the Senior Vice President of Market Access, Policy and Government Affairs at Intra-Cellular Therapies. John has over 25 years of experience in the pharmaceutical and healthcare industries.

Bardi began their career in 1991 as the Vice President of Clinical and Professional Services at The Children's Hospital of Philadelphia. John then spent five years as the Vice President of Longterm Care Channel in the Managed Markets Division at GlaxoSmithKline. In 2002, they became the Vice President of Managed Market Sales at Bristol-Myers Squibb, where they were responsible for directing Managed Markets Field Organization activities for all payer channels.

From 2010 to 2019, Bardi served as the Vice President of Public Affairs and Digital Medicine Business Development at Otsuka America Pharmaceutical. In this role, they were responsible for developing and executing digital health strategy and business development initiatives. John also oversaw public affairs activities, including government affairs, policy, and external communications.

Bardi has served on the Board of Directors for the National Pharmaceutical Council from December 2012 to December 2014. John is also a member of the Tech Council of Maryland Board of Directors.

John A. Bardi has a Master's in Health Services Administration from The George Washington University School of Business and a Bachelor's degree in Public Administration from West Chester University of Pennsylvania.

They are on a team with Andrew Satlin - Executive Vice President, Chief Medical Officer, Lawrence J. Hineline - Senior Vice President of Finance & Chief Financial Officer, and Karen Patruno Sheehy - SVP, Chief Compliance Officer. John A. Bardi reports to Sharon Mates, Founder, Chairman & Chief Executive Officer.